Firms’ faith in stock buybacks not always well-placed
The ultimate test of whether buybacks are good deals for shareholders hinges on whether the price paid for the stock proves over time to have been a bargain or inflated.
The ultimate test of whether buybacks are good deals for shareholders hinges on whether the price paid for the stock proves over time to have been a bargain or inflated.
Earthquakes and flooding took a toll on Baldwin & Lyons Inc.’s first quarter results, the Indianapolis-based insurer announced Thursday morning.
Indianapolis-based Medivative Technologies plans to build a 9,000-square-foot addition to its east-side facility and spend $2.5 million to equip it. The expansion should create 15 jobs.
The Carmel-based life and health insurer earned $54 million, or 19 cents per share, topping the expectations of Wall Street analysts.
The Food and Drug Administration says it has approved a new diabetes pill from Boehringer Ingelheim and Eli Lilly for patients who can't control their blood sugar with older medicines.
Demand for medical office buildings is set to grow twice as fast as it was expected to in the next decade, thanks to the Patient Protection and Affordable Care Act.
Indiana hospitals could pull in more than $100 million a year from the federal government under a new assessment fee included in the state’s 2011 budget bill.
The hospital paid $31,500 to settle a class-action lawsuit brought by a patient who claimed St. Vincent used a debt collector that was not licensed in Indiana.
A look at some major legislation considered this year by the Indiana General Assembly.
Republican Gov. Mitch Daniels said Friday he will sign restrictive abortion legislation and make Indiana the first state to cut off all government funding for Planned Parenthood, a move likely to boost his credentials among social conservatives as he considers whether to run for president.
A bill requiring criminal background checks for anyone seeking new Indiana licenses as a doctor, dentist, nurse or several other health care jobs is heading to the governor for approval.
Warsaw-based orthopedic implant maker Zimmer Holdings Inc. said Thursday its first-quarter profit rose 2 percent on higher sales of reconstructive, dental and other products.
Indianapolis-based Dow AgroSciences on Thursday reported sales of $1.6 billion in its first quarter, up 17 percent from the same period last year due to higher volume and increased prices.
Eli Lilly and Co. said Wednesday that a federal court is blocking low-cost generic versions of Cymbalta from the market until the patents supporting the drug expire.
The Indiana House voted 66-32 Wednesday to approve a bill cutting the $3 million in federal money the state distributes to the organization for family planning and health programs. The Senate approved the measure earlier this month.
Indianapolis-based WellPoint Inc. is the third health insurer in the past week to beat analysts’ predictions by a huge margin and raise its full-year forecast.
Cicero-based developer Mainstreet Property Group LLC plans to build a $13.3 million senior health care center in Westfield. The 65,000-square assisted living facility will employ about 150 people when it opens in 2012.
California-based Hycor Biomedical Inc. plans to move its headquarters to central Indiana, creating as many as 20 jobs in the next two years, state economic development officials announced Wednesday morning.
The Indianapolis-based health insurer earned $2.44 per share and raised its full-year profit forecast by 40 cents per share.
Genzyme Corp., the drugmaker bought by Sanofi-Aventis SA this month, sued Zimmer Holdings Inc. and Anika Therapeutics Inc. alleging the companies’ treatments for arthritic knee pain infringe a patent.